Dev, H.; Hu, Z.; Blumenfeld, J.D.; Sharbatdaran, A.; Kim, Y.; Zhu, C.; Shimonov, D.; Chevalier, J.M.; Donahue, S.; Wu, A.;
et al. The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study. J. Clin. Med. 2025, 14, 1449.
https://doi.org/10.3390/jcm14051449
AMA Style
Dev H, Hu Z, Blumenfeld JD, Sharbatdaran A, Kim Y, Zhu C, Shimonov D, Chevalier JM, Donahue S, Wu A,
et al. The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study. Journal of Clinical Medicine. 2025; 14(5):1449.
https://doi.org/10.3390/jcm14051449
Chicago/Turabian Style
Dev, Hreedi, Zhongxiu Hu, Jon D. Blumenfeld, Arman Sharbatdaran, Yelynn Kim, Chenglin Zhu, Daniil Shimonov, James M. Chevalier, Stephanie Donahue, Alan Wu,
and et al. 2025. "The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study" Journal of Clinical Medicine 14, no. 5: 1449.
https://doi.org/10.3390/jcm14051449
APA Style
Dev, H., Hu, Z., Blumenfeld, J. D., Sharbatdaran, A., Kim, Y., Zhu, C., Shimonov, D., Chevalier, J. M., Donahue, S., Wu, A., RoyChoudhury, A., He, X., & Prince, M. R.
(2025). The Role of Baseline Total Kidney Volume Growth Rate in Predicting Tolvaptan Efficacy for ADPKD Patients: A Feasibility Study. Journal of Clinical Medicine, 14(5), 1449.
https://doi.org/10.3390/jcm14051449
